Cures 2.0 legislation that was introduced on Capitol Hill in 2021 includes a provision (Section 408) that would establish coverage for pharmacogenetic consultations delivered by qualified clinical pharmacists.

ACCP has been engaged in an ongoing series of meetings with the lead Congressional Offices to help consolidate support on Capitol Hill for this exciting legislative proposal.

As the 117th Congress concludes its legislative work, ACCP is already looking ahead to 2023. We urge lawmakers to introduce similar legislation in the 118th Congress.

Now we need your help.

Members of Congress need to hear directly from clinical pharmacists about the importance of pharmacogenomic testing, and the emerging world of precision medicine, to our overall goal of helping patients achieve medication optimization.

Contacting the offices of your elected officials is simple. We have prepared a letter for you to review and edit. Simply follow the instructions to send this message to Capitol Hill.

Please take the time to personalize the letter by providing additional information about your practice and the patients you care for. Pharmacists across the country are working under extraordinary circumstances to improve patient outcomes through team-based models of care. As policymakers assess the strengths and weaknesses of our nation's healthcare infrastructure, it is vital they hear about the ongoing work of clinical pharmacists.

Thank you for your participation in this important advocacy effort. Please also sign up for the Get the Medications Right Institute to stay on top of exciting developments related to our work in Washington, DC.